Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

PaperCitations, authors & open-access status

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 345 citations, 2015 year and bronze oa status.

345
Citations
2015
Year
bronze
OA Status

Related on ScholarIQ

Janice Weinberg
Author
Sarah McLaughlin
Author
Systemic Sclerosis and Related Diseases
Topic
Systemic Sclerosis and Related Diseases
Topic
Connective Tissue Growth Factor Research
Topic
Skin Diseases and Diabetes
Topic
470M+ articles · free account